News Article

Join Candesic at LaingBuisson’s ‘Investing in Healthcare’ conference on Thursday, March 28

6 March 2024

Senior Partner Dr Michelle Tempest will be taking to the stage at The Royal College of Surgeons of England alongside Valentina Milanova, Founder and CEO at Daye, Tess Isabelle Cosad, CEO and Co-Founder of Béa Fertility, Dr Milla Marinova, Co-Founder and CEO at R8ER, and Professor Asif Ahmed Chairman and CEO of MirZyme Therapeutics in a session entitled Emerging Markets across Women’s Health and FemTech.

Dr Michelle will be in compelling company. Tess’ Béa Fertility is bringing affordable clinical grade fertility treatment into the home, while Valentina’s Daye is on a mission to bridge the gender gap in product innovation. Professor Asif Ahmed is the world-renowned scientist who discovered protective pathways that can be used to predict, prevent and treat preeclampsia, and Dr Milla co-founded a digital evaluation platform that connects technology with investment.

Panellists at other sessions include Benedetto De Biasio (Wren house Infrastructure Investments), Marco Bonaiti (Apax), Andrew Nicholson from Baird, and Sharon Spangenberg from Onex.

Click here to find out more about the event and use a discount code INV24SPKR10 for 10% off your ticket.